6-Mercaptopurine and inflammatory bowel disease: Hidden ground for the cytomegalovirus

Canadian Journal of Gastroenterology

Volumn 17, Issue 5, 2003, Pages 319-322

  Hookey, L C ^a   Depew, W ^a   Boag, A ^a   Vanner, Stephen J ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

6 Mercaptopurine; Azathioprine; Crohn's disease; Cytomegalovirus; Inflammatory bowel disease

Indexed keywords

AZATHIOPRINE; CEPHALOSPORIN; CORTICOSTEROID; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MACROLIDE; MERCAPTOPURINE; OXYGEN; STEROID;

ACUTE PANCREATITIS; ADULT; ARTIFICIAL VENTILATION; BONE MARROW SUPPRESSION; BRONCHUS BIOPSY; CASE REPORT; CLINICAL FEATURE; COLITIS; CROHN DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; ENTERITIS; FEMALE; GRAM STAINING; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION SENSITIVITY; OXYGEN THERAPY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; THORAX RADIOGRAPHY; TRACHEOBRONCHIAL TOILET; VIRUS CULTURE; VIRUS PNEUMONIA;

EID: 0038786815     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2003/824547     Document Type: Review

References (22)

1. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-Mercaptopurine in Crohn's disease. A meta-analysis. Ann Intern Med 1995;123:132-42.
2. Lennard L. The clinical pharmacology of 6-mercaptopurine. Eur J Clin Pharmacol 1992;43:329-39.
3. Baklien K, Brandtzaeg P. Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon. Clin Exp Immunol 1975;22:197-209.
4. Present DH, Meltzer SJ, Krumholz MP, Wolke A, Korelitz BI. 6-Mercaptopurine in the management of inflammatory bowel disease: Short- and long-term toxicity. Ann Intern Med 1989;111:641-9.
5. Papadakis KA, Tung JK, Binder SW, et al. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol 2001;96:2137-42.
6. Cottone M, Pietrosi G, Martorana G, et al. Prevalence of cytomegalovirus in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 2001;96:773-5.
7. Orvar K, Murray J, Carmen G, Conklin J. Cytomegalovirus infection associated with onset of inflammatory bowel disease. Dig Dis Sci 1993;38:2307-10.
8. Vega R, Menacho M, Domenech E, et al. Cytomegalovirus infection in patients with inflammatory bowel disease. Am J Gastroenterol 1999;94:1053-6.
9. Kaufman HS, Kahn AC, Iacobuzio-Donahue C, Talamini MA, Lillemoe KD, Hamilton SR. Cytomegaloviral enterolcolitis: Clinical associations and outcome. Dis Colon Rectum 1999;42:24-30.
10. Hengel H, Koszinowski UH. Inhibition of MHC class I function by cytomegalovirus. In: Medveczky PG, Friedman H, Bendinelli M, eds. Herpesviruses and Immunity. New York: Plenum Press, 1998:247-64.
11. Rubin RH. Infection in the renal transplant patient. In: Rubin RH, Young LS, eds. Clinical Approach to Infection in the Compromised Host. New York: Plenum, 1981:553-605.
12. Dummer JS, Hardy A, Poorsatter A, et al. Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation. 1983;36:259-67.
13. Ginsburg CH, Dambrauskas JT, Ault KA, Falchuk ZM. Impaired natural killer cell activity in patients with inflammatory bowel: Evidence for a qualitative defect. Gastroenterology 1983;85:846-51.
14. Dichter JR, Levine SJ, Shelhamer JH. Approach to the immunocompromised host with pulmonary symptoms. Hematol Oncol Clin North Am 1993;7:887-912.
15. Verra F, Hmouda H, Rauss A, et al. Bronchoalveolar lavage in immunocompromised patients: Clinical and functional consequences. Chest 1992;101:1215-20.
16. Snyder C, Ramsay NK, McGlave PB, et al. Diagnostic open lung biopsy after bone marrow transplantation. J Pediatr Surg 1990;25:871-7.
17. Crumpacker CS. Cytomegaolvirus. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 5th edn. Philadelphia: Churchhill Livingstone, 2000:1586-99.
18. Schuster EA, Bencke JS, Tegtmeier GE, et al. Monoclonal antibody for rapid laboratory detection of cytomegalovirus infections: Characterization and diagnostic application. Mayo Clin Proc 1985;60:577-85.
19. Murray BM, Amsterdam D, Gray V, et al. Monitoring and diagnosis of cytomegalovirus infection in renal transplantation. J Am Soc Nephrol 1997;8:1448-57.
20. Tanabe K, Tokumoto T, Ishikawa N, et al. Comparative study of cytomegalovirus antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation. Transplantation 1997;64:1721-5.
21. Stanier P, Kitchen AD, Taylor DL, et al. Detection of human cytomegalovirus in peripheral mononuclear cells and urine samples using PCR. Mol Cell Probes 1992;6:51-8.
22. Bendiksen S, Van Ghelue M, Rekvig OP, Gutteberg T, Haga HJ, Moens U. A longitudinal study of human cytomegalovirus serology and viruria fails to detect active viral infection in 20 systemic lupus erythematosus patients. Lupus 2000;9:120-6.